Increased risk of diabetes mellitus in relation to the severity of psoriasis, concomitant medication, and comorbidity: A nationwide population-based cohort study
Authors:
- 1 April 2014
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 70 (4) , 691-698
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare RegistryJournal of the European Academy of Dermatology and Venereology, 2012
- Prevalence of the Metabolic Syndrome in PsoriasisArchives of Dermatology, 2011
- Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasisAnnals of the Rheumatic Diseases, 2010
- Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studiesEuropean Journal of Epidemiology, 2010
- Psoriasis and the metabolic syndromeDermatologic Therapy, 2010
- The Risk of Stroke in Patients with PsoriasisJournal of Investigative Dermatology, 2009
- Psoriasis and the Risk of Diabetes and HypertensionArchives of Dermatology, 2009
- The Risk of Mortality in Patients With PsoriasisArchives of Dermatology, 2007
- Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasisArchives of Dermatological Research, 2006
- A Randomized Trial of Methotrexate in Newly Diagnosed Patients with Type 1 Diabetes MellitusClinical Immunology, 2000